# Crispr Therapeutics AG (CRSP) — Operating Income

## Annual Operating Income (USD)

| Year | Operating Income |
| --- | --- |
| 2025 | -$665M |
| 2024 | -$467M |
| 2023 | -$223M |
| 2022 | -$673M |
| 2021 | $374M |
| 2020 | -$354M |
| 2019 | $47M |
| 2018 | -$159M |
| 2017 | -$65M |
| 2016 | -$68M |
| 2015 | -$26M |

## Quarterly Operating Income (USD)

| Quarter | Operating Income |
| --- | --- |
| 2026-03-31 | -$130M |
| 2025-09-30 | -$132M |
| 2025-06-30 | -$229M |
| 2025-03-31 | -$148M |
| 2024-09-30 | -$110M |
| 2024-06-30 | -$151M |
| 2024-03-31 | -$141M |
| 2023-09-30 | -$132M |
| 2023-06-30 | -$95M |
| 2023-03-31 | -$64M |
| 2022-09-30 | -$182M |
| 2022-06-30 | -$183M |
| 2022-03-31 | -$176M |
| 2021-09-30 | -$129M |
| 2021-06-30 | $763M |
| 2021-03-31 | -$115M |
| 2020-09-30 | -$92M |
| 2020-06-30 | -$81M |
| 2020-03-31 | -$74M |
| 2019-09-30 | $139M |
| 2019-06-30 | -$55M |
| 2019-03-31 | -$48M |
| 2018-09-30 | -$49M |
| 2018-06-30 | -$37M |

Source: [MarketCapTrends](https://marketcaptrends.com/company/CRSP/operating-income)